ISIN | CH0210193584 |
---|---|
Valor Number | 21019358 |
Bloomberg Global ID | UBS65QD SW |
Fund Name | UBS (CH) Suisse - 65 (CHF) Q-dist |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Asset Allocation |
EFC Category | Multi-Asset Global Advanced Markets Aggressive |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Well diversified portfolio with a focus on selected Swiss bonds, equities and real estate, complemented by a component of global bonds and equities|Equity weighting 65% |
Peculiarities |
Current Price * | 128.00 CHF | 22.04.2025 |
---|---|---|
Previous Price * | 127.68 CHF | 17.04.2025 |
52 Week High * | 137.78 CHF | 13.02.2025 |
52 Week Low * | 123.24 CHF | 09.04.2025 |
NAV * | 128.00 CHF | 22.04.2025 |
Issue Price * | 128.15 CHF | 22.04.2025 |
Redemption Price * | 128.15 CHF | 22.04.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 443,410,828 | |
Unit/Share Assets *** | 23,368,874 | |
Trading Information SIX |
YTD Performance | -1.84% |
31.12.2024 - 22.04.2025
31.12.2024 22.04.2025 |
---|---|---|
1 month | -5.80% |
24.03.2025 - 22.04.2025
24.03.2025 22.04.2025 |
3 months | -4.72% |
22.01.2025 - 22.04.2025
22.01.2025 22.04.2025 |
6 months | -3.09% |
22.10.2024 - 22.04.2025
22.10.2024 22.04.2025 |
1 year | +2.72% |
22.04.2024 - 22.04.2025
22.04.2024 22.04.2025 |
2 years | +6.12% |
24.04.2023 - 22.04.2025
24.04.2023 22.04.2025 |
3 years | +0.15% |
22.04.2022 - 22.04.2025
22.04.2022 22.04.2025 |
5 years | +21.71% |
22.04.2020 - 22.04.2025
22.04.2020 22.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UBS InvF Equities USA Index I-X-acc | 12.32% | |
---|---|---|
UBS CH IF3 RealEstSwitzFdsIdxNSL I-Xacc | 9.92% | |
UBS (CH) IF S&M Cap Equities Switz I-X | 8.84% | |
UBS (CH) IF Bds CHF Inl Corp Pasv II U-X | 7.16% | |
Nestle SA | 4.88% | |
UBS (CH) IF Bds CHF Aus Corp Pasv II U-X | 4.69% | |
UBS (CH) IF Bds CHF Prime Ausland U-X | 4.69% | |
Roche Holding AG | 4.49% | |
Novartis AG Registered Shares | 4.11% | |
UBS(Lux)FS MSCI EMU EUR Adis | 4.10% | |
Last data update | 28.02.2025 |
TER | 1.05% |
---|---|
TER date | 31.08.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.95% |
Ongoing Charges *** | 1.05% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |